Some general observations can be made upon analysis of the extended antifungal and toxicity assays. The level of activity for the most active compounds is comparable to the activity of the control antifungal drugs against the respective pathogen (Tables and in SI). Generally, good activity in the initial CO-ADD screening translates to good activity across the whole panel of Candida and Cryptococcus strains used in this work.